Cite
HARVARD Citation
Mascarella, M. et al. (n.d.). Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit. European journal of cancer. pp. S128-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mascarella, M. et al. (n.d.). Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit. European journal of cancer. pp. S128-. [Online].